Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 14/20 | 0.58 |
| ▸ | LPL | P06858 | 13/20 | 0.58 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.42 |
| ▸ | P4HB | P07237 | 1/20 | 0.41 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.40 |
| ▸ | KDR | P35968 | 1/20 | 0.40 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.40 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.40 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17277080 | 0.90 | LIPG (0.54) | LIPGLPLROCK1P4HBPDGFRB | |
| SCHEMBL23770467 | 0.86 | LIPG (0.47) | LIPGLPLROCK1P4HBPRMT5 | |
| SCHEMBL21909819 | 0.84 | LIPG (0.50) | LIPGLPLROCK1P4HBPDGFRB | |
| SCHEMBL29653625 | 0.84 | LIPG (0.66) | LIPGLPLP4HBPDGFRBKDR | |
| SCHEMBL19533269 | 0.84 | LIPG (0.66) | LIPGLPLP4HBPDGFRBKDR | |
| SCHEMBL623701 | 0.81 | LIPG (0.62) | LIPGLPLROCK1P4HBPDGFRB | |
| SCHEMBL29871639 | 0.81 | LIPG (0.62) | LIPGLPLROCK1P4HBPDGFRB | |
| SCHEMBL23303470 | 0.81 | LIPG (0.62) | LIPGLPLROCK1P4HBPDGFRB | |
| SCHEMBL13469834 | 0.81 | LIPG (0.40) | LIPGLPLROCK1HIF1A | |
| SCHEMBL13454815 | 0.81 | LIPG (0.62) | LIPGLPLHIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9540566-B2 | Devices for high-frequency technology, liquid-crystalline media and compounds | MERCK PATENT GMBH (DE) | 2017-01-10 | — | — | US | disclosed |
| US-20160046866-A1 | DEVICES FOR HIGH-FREQUENCY TECHNOLOGY, LIQUID-CRYSTALLINE MEDIA AND COMPOUNDS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2016-02-18 | — | — | US | disclosed |
| US-9193905-B2 | Devices for high-frequency technology, liquid-crystalline media and compounds | MERCK PATENT GMBH (DE) | 2015-11-24 | — | — | US | disclosed |
| EP-2507341-B1 | COMPONENTS FOR HIGH FREQUENCY TECHNOLOGY, LIQUID CRYSTAL MEDIA AND COMPOUNDS | MERCK PATENT GMBH (DE) | 2014-10-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160046866-A1 | DEVICES FOR HIGH-FREQUENCY TECHNOLOGY, LIQUID-CRYSTALLINE MEDIA AND COMPOUNDS | MCM5, MCM3, MCM7 | LIPG 4445/4885LPL 4501/4885ROCK1 471/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.